| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/08/2010 | US20100173947 New Indications for Direct Thrombin Inhibitors |
| 07/08/2010 | US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof |
| 07/08/2010 | US20100173944 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 07/08/2010 | US20100173934 Combinations of therapeutic agents for treating cancer |
| 07/08/2010 | US20100173928 Phosphorylation and regulation of AKT/PKB by the rictor-mTOR complex |
| 07/08/2010 | US20100173924 Novel heterocycle compounds and uses thereof |
| 07/08/2010 | US20100173923 4 (pyrrolopyridinyl)pyrimidinyl-2-amine derivatives |
| 07/08/2010 | US20100173922 Polymorphisms for Predicting Disease and Treatment Outcome |
| 07/08/2010 | US20100173918 Methods and compositions for determining the efficacy of breast cancer therapeutics |
| 07/08/2010 | US20100173917 Urea derivatives as abl modulators |
| 07/08/2010 | US20100173913 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 07/08/2010 | US20100173910 Triaminopyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 07/08/2010 | US20100173906 Substituted 3,4,6,7-Tetrahydro-5H-1,2a,4a,8-Tetraazacyclopenta[cd]Phenalenes and Methods |
| 07/08/2010 | US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 07/08/2010 | US20100173885 Organometeallic compounds |
| 07/08/2010 | US20100173873 Treatment of metastasized tumors |
| 07/08/2010 | US20100173870 Phosphonate Compounds |
| 07/08/2010 | US20100173865 Anti-Cancer Agent-Hyaluronic Acid Conjugate Compositions and Methods |
| 07/08/2010 | US20100173864 Compositions including triciribine and one or more platinum compounds and methods of use thereof |
| 07/08/2010 | US20100173863 2-Fluoronucleosides |
| 07/08/2010 | US20100173862 Injectable, injection solution, and injection kit preparation |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173835 Peptides for Treatment of Obesity |
| 07/08/2010 | US20100173832 Anticancerous polymeric agents |
| 07/08/2010 | US20100173413 Pyridine compounds |
| 07/08/2010 | US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/08/2010 | US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/08/2010 | US20100173020 Uses of ammonium chloride |
| 07/08/2010 | US20100173013 Treatment of neoplastic disorders using combination therapies |
| 07/08/2010 | US20100173002 Microcapsules with improved shells |
| 07/08/2010 | US20100173001 Metal Ion-Treated Biocompatible Polymers Useful for Nanoparticles |
| 07/08/2010 | US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound |
| 07/08/2010 | US20100172977 Abscisic acid against cancer |
| 07/08/2010 | US20100172976 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 07/08/2010 | US20100172975 Treatment of hyperproliferative disorders with diarylhydantoin compounds |
| 07/08/2010 | US20100172961 Encapsulated Peptide Amphiphile Nanostructures |
| 07/08/2010 | US20100172939 Treating neoplasms with neurotoxin |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172921 Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 07/08/2010 | US20100172914 Methods and materials related to trail isoforms |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins |
| 07/08/2010 | US20100172910 Human sarcoma-associated antigens |
| 07/08/2010 | US20100172908 Methods and compositions for treating diseases targeting maba1 |
| 07/08/2010 | US20100172903 Combination of an Anti-Ep-CAM Antibody with a Chemotherapeutic Agent |
| 07/08/2010 | US20100172902 Method for treating a vcam-1 mediated disease |
| 07/08/2010 | US20100172901 Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment |
| 07/08/2010 | US20100172900 Human Monoclonal Antibodies to BTLA And Methods of Use |
| 07/08/2010 | US20100172893 Use of Reversine and Analogs For Treatment of Cancer |
| 07/08/2010 | US20100172892 Hyaluronidase and method of use thereof |
| 07/08/2010 | US20100172888 Hcv-reactive t cell receptors |
| 07/08/2010 | US20100172885 Multipotent Adult Stem Cells And Uses of Multipotent Adult Stem Cells To Treat Inflammation |
| 07/08/2010 | US20100172880 Dna methylation markers based on epigenetic stem cell signatures in cancer |
| 07/08/2010 | US20100172878 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes |
| 07/08/2010 | US20100172877 Compositions and methods of use of an oncolytic vesicular stomatitis virus |
| 07/08/2010 | US20100172872 Treatment of Cancer Using HSV Mutant |
| 07/08/2010 | US20100172870 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 07/08/2010 | US20100172868 Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| 07/08/2010 | US20100172867 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds |
| 07/08/2010 | US20100172844 Albumin binding molecules and uses thereof |
| 07/08/2010 | US20100172838 Endometrial biomarkers |
| 07/08/2010 | US20100172837 MN Gene and Protein |
| 07/08/2010 | US20100172835 Methods and compositions for synaphically-targeted treatment for cancer |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | DE102009003975A1 Benzothiazolonderivate Benzothiazolonderivate |
| 07/08/2010 | DE102009003954A1 Pyridazinonderivate Pyridazinone derivatives |
| 07/08/2010 | CA2748982A1 Thienopyridines as pharmacologically active agents |
| 07/08/2010 | CA2748757A1 Anti-lymphotoxin antibodies |
| 07/08/2010 | CA2748729A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same |
| 07/08/2010 | CA2748517A1 Prophylactic/therapeutic agent for cancer |
| 07/08/2010 | CA2748491A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
| 07/08/2010 | CA2748276A1 Substituted pyrazolo [3, 4-b] pyridine compounds |
| 07/08/2010 | CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors |
| 07/08/2010 | CA2748066A1 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
| 07/08/2010 | CA2747404A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/08/2010 | CA2746790A1 Toluidine sulfonamides and their use |
| 07/08/2010 | CA2746423A1 Aminopyrazole compounds as chki inhibitors |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | CA2745295A1 Modulators of toll-like receptors |
| 07/08/2010 | CA2745071A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof |
| 07/08/2010 | CA2740806A1 Anti-pd-l1 antibodies and their use to enhance t-cell function |
| 07/08/2010 | CA2740521A1 Use of ammonium chloride in therapy |
| 07/08/2010 | CA2738243A1 Formulations of single domain antigen binding molecules |
| 07/07/2010 | EP2204448A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 07/07/2010 | EP2204398A1 Camptothecin polymer derivative and uses of the same |
| 07/07/2010 | EP2204378A1 A inhibiting agent for inhibition of angiogenesis, a method for preparing the agent, a method for modifying the agent and its use for manufacturing a medicament for treating tumor |
| 07/07/2010 | EP2204367A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 07/07/2010 | EP2204191A1 Monoclonal antibodies to hepatocyte growth factor |
| 07/07/2010 | EP2204186A1 Immunogenic complexes and methods relating thereto |
| 07/07/2010 | EP2204183A1 Treatment of neuroblastoma |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP2203479A2 Inhibition of angiogenesis |
| 07/07/2010 | EP2203473A1 Sdf-1-based glycosaminoglycan antagonists and methods of using same |
| 07/07/2010 | EP2203453A1 Pyrazolo[5, 1-c] [1,2,4]triazines, methods for preparation and use thereof |
| 07/07/2010 | EP2203452A1 Pyrrolopyrimidine compounds |
| 07/07/2010 | EP2203449A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 07/07/2010 | EP2203447A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/07/2010 | EP2203442A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 07/07/2010 | EP2203440A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/07/2010 | EP2203437A1 Chiral cis-imidazolines |